Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion

Diabetes
N PørksenPeter C Butler

Abstract

Glucagon-like peptide 1 (GLP-1) is a peptide hormone that is released from the gut after luminal stimulation. The hormone is a potent insulin secretagogue and is a potential novel pharmaceutical adjuvant in the treatment of NIDDM. Insulin is secreted as a series of punctuated secretory bursts superimposed on a basal insulin release. Recently, the contribution of these secretory bursts to overall insulin secretion has been evaluated, and studies using catheterization across the pancreas in a canine model and studies using deconvolution in humans have revealed that the majority of insulin is released during these secretory bursts. Moreover, the main regulation of insulin secretion is through perturbation of mass and frequency of these secretory bursts. The mode of delivery of insulin into the circulation seems important for insulin action, and it is therefore important to know the impact of a potential therapeutic insulin secretagogue on the mode of insulin secretion. To assess the effects of GLP-1 on the mass, frequency, amplitude, and overall contribution of pulsatile insulin secretion, we used a recently validated deconvolution model to examine these variables before and during infusion of GLP-1 in eight healthy men (age 28 +/...Continue Reading

Citations

Oct 23, 2008·Endocrine Reviews·Johannes D VeldhuisSteven M Pincus
Apr 23, 1999·Journal of Basic and Clinical Physiology and Pharmacology·M E Patti, C R Kahn
May 19, 2009·Medical Hypotheses·M Reza MirbolookiJonathan R T Lakey
Feb 1, 2015·Molecular Aspects of Medicine·Leslie S SatinArthur S Sherman
Mar 5, 2003·Pharmacological Reviews·Máire E Doyle, Josephine M Egan
Mar 8, 2002·American Journal of Physiology. Endocrinology and Metabolism·Hans-Georg JoostBernard Thorens
Jun 27, 2000·Diabetes/metabolism Research and Reviews·P Bergsten
Jan 30, 2002·Diabetes·Niels PørksenOle Schmitz
Mar 11, 2005·Diabetes/metabolism Research and Reviews·Juris J Meier, Michael A Nauck
Feb 8, 2002·American Journal of Physiology. Endocrinology and Metabolism·Suzanne RogersJames D Best
Nov 10, 2005·American Journal of Physiology. Endocrinology and Metabolism·R A RitzelP C Butler
Nov 10, 2005·Journal of Endocrinological Investigation·C M RotellaE Mannucci
Nov 11, 2009·Acta Biochimica Et Biophysica Sinica·Hu ZhouKan Liao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.